Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre
Clinical trials sponsored by Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre, explained in plain language.
-
Can a 'Social Prescription' save lives? new trial aims to help women stick to heart failure meds
Disease control Recruiting nowThis study is testing if 'social prescribing' can help women with heart failure take their medications more consistently and feel better. Social prescribing connects patients with a 'link worker' who helps them find community support for needs like transportation, housing, or lon…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists test safer methods to build food allergy tolerance
Disease control Recruiting nowThis study is testing whether using lower doses or processed versions of food allergens can help people with peanut, milk, or egg allergies build tolerance with fewer allergic reactions during treatment. Researchers will compare different oral immunotherapy approaches in 360 part…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New pacemaker technique aims to stop heart failure before it starts
Disease control Recruiting nowThis study tests whether placing a pacemaker wire in a different part of the heart (left bundle) is better than the standard placement (right ventricle) for patients who need constant pacing due to heart block. Researchers want to see if the new placement reduces heart failure ev…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Heart help for failing kidneys: old drug, new hope?
Disease control Recruiting nowThis study is testing if a diabetes medication called canagliflozin can improve heart structure and function in people with advanced kidney disease, including those on dialysis. About 92 participants will take either the drug or a placebo for one year, with doctors using heart MR…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Scientists test best shot strategy to protect most vulnerable from COVID and flu
Disease control Recruiting nowThis study aims to find the best way to give COVID-19 booster shots and seasonal flu vaccines to adults with weakened immune systems. Researchers want to know if getting both shots on the same day works as well as getting them a month apart, and if getting COVID boosters every 3 …
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Tool aims to cut risky pill burden for arthritis patients
Disease control Recruiting nowThis study aims to see if providing doctors with a medication review tool and giving patients educational brochies can help safely reduce the number of potentially harmful or unnecessary medications taken by older adults with rheumatic diseases. It will involve about 100 particip…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Can home workouts get frail patients stronger for kidney transplant?
Disease control Recruiting nowThis small pilot study is testing whether a virtual home-based exercise and education program is practical for frail patients waiting for a kidney transplant. The goal is to see if patients can and will follow the program, and to gather information to plan a larger future study. …
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Can IBD patients take less medicine? new study aims to find out
Disease control Recruiting nowThis study is testing whether patients with Crohn's disease or ulcerative colitis who are in deep remission can safely reduce the frequency of their ustekinumab injections. Researchers want to see if patients can space out their shots from every 4 weeks to every 8 weeks, or from …
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New Heart-Zapping tech aims to stop deadly rhythms deeper and safer
Disease control Recruiting nowThis study is testing a new medical device that combines two types of energy to treat a dangerous, fast heart rhythm called ventricular tachycardia (VT). The goal is to see if using pulsed field energy together with standard radiofrequency energy can create deeper, more effective…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Blood thinner doubles as infection fighter in major trial
Disease control Recruiting nowThis study is for people with a serious Staph blood infection who are already taking certain blood thinners. It will test if switching their medication to dabigatran, a blood thinner that may also fight the bacteria, leads to better recovery. Researchers will compare outcomes lik…
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New push to stop disease spread in prisons
Disease control Recruiting nowThis study aims to make prison needle exchange programs work better in nine Canadian federal prisons. It focuses on helping people who inject drugs in prison access clean needles to prevent the spread of HIV and hepatitis C. Researchers will test different support strategies over…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New scan could predict liver crises without surgery
Diagnosis Recruiting nowThis study is testing whether a simple, non-invasive scan can accurately detect and monitor high blood pressure in the liver (portal hypertension) in people with advanced liver disease. Researchers will follow 200 participants to see if the scan results can predict serious liver …
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
Can a simple pill stop a dangerous gut infection from coming back?
Prevention Recruiting nowThis study aims to prevent repeat Clostridioides difficile (C. diff) infections in people who recently had one and need to take antibiotics again. It will test if taking oral vancomycin (an antibiotic) alongside the new antibiotic course can protect the gut and stop C. diff from …
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Mar 30, 2026 14:34 UTC
-
Scientists race to slash TB prevention treatment from months to weeks
Prevention Recruiting nowThis study aims to find shorter, safer drug regimens to prevent latent tuberculosis (TB) infection from turning into active disease. Researchers are testing 1-2 month daily pill courses against the current standard 4-month treatment in 1,800 adults and children. The goal is to id…
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Mar 02, 2026 15:29 UTC
-
Researchers test drug to make surgery numbing last longer
Symptom relief Recruiting nowThis study aims to find the best dose of a drug called dexmedetomidine to make a numbing nerve block last longer after arm surgery. Researchers will compare three different doses added to the standard numbing medicine. The goal is to provide patients with more extended pain relie…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Fertility Treatments' hidden toll on Women's sex lives revealed
Knowledge-focused Recruiting nowThis study aims to understand how infertility and fertility treatments affect women's sexual function and behavior. Researchers will ask 500 women undergoing fertility treatment to complete anonymous questionnaires about their sexual health. The goal is to help healthcare provide…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC
-
New monitoring system could help keep tiniest babies off breathing machines
Knowledge-focused Recruiting nowThis study is testing whether a new monitoring system is practical and acceptable for tracking extremely premature babies after their breathing tube is removed. Researchers will observe 20 very small babies (under 2.2 pounds) to see if combining multiple types of monitoring data …
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Listening to bubbles to help tiny lungs breathe
Knowledge-focused Recruiting nowThis study aims to see if the sounds from a breathing support machine (called bubble CPAP) can be used to monitor how well it's working for premature babies. Researchers will record sounds from the machine and measure the air pressure delivered to 30 infants in the NICU. The goal…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Scientists map the path of blindness in rare genetic disorder
Knowledge-focused Recruiting nowThis study aims to understand how vision gets worse over time in people with Zellweger Spectrum Disorder (ZSD), a rare genetic condition. Researchers will follow 30 participants for five years, performing detailed eye exams and vision tests each year. The goal is to create a time…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
New app aims to end the 'Trial-and-Error' for endometriosis care
Knowledge-focused Recruiting nowThis study is testing whether a new smartphone app called 'elleFA' is practical and helpful for women with endometriosis. Twenty participants will use the app for six months to track their symptoms and complete monthly surveys. The main goal is to see if women will consistently u…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Could a simple finger prick replace painful blood draws?
Knowledge-focused Recruiting nowThis study aims to find out if a simple finger-prick blood spot test can measure inflammation markers as accurately as a traditional blood draw from the arm. Researchers will compare both methods in 50 adults after they experience a planned, temporary stressor like getting a vacc…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC
-
Scientists track rare genetic disorders to unlock better care
Knowledge-focused Recruiting nowThis study aims to better understand a group of rare, inherited disorders called peroxisome biogenesis disorders (PBDs). Researchers will follow about 244 patients over time, collecting health records, images, and samples to map out how these diseases progress. The goal is to ide…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC